Percutaneous laser revascularisation for refractory angina pectoris

 
Guidance issued
 
IPG Number: IPG302

Summary

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on percutaneous laser revascularistion for refractory angina pectoris. Full guidance has also been published on laser transmyocardial revascularistion for refractory angina pectoris.

Description

Patients with refractory angina pectoris have chest pain (because of insufficient oxygen delivery to their heart muscle) that cannot be controlled by optimal medical or surgical management. Percutaneous laser revascularisation involves insertion of a catheter into major vessels of the groin, which is advanced to the heart, to drill holes on the heart muscle using a laser beam. The aim is to enable blood flow from the heart chambers into the heart muscle, to relieve myocardial ischaemia and reduce chest pain.

OPCS4.6 Code(s):

Details

Arrangement:
Do not use
Topic area:
Cardiovascular
Specialty:
Cardio-thoracic surgery
Specialist advice sought from:

Cardiothoracic surgeons of GB and Ireland

British cardiovascular intervention society

Date notified to NICE:
01 April 2002
Provisional consultation date:
Summer 2007
Guidance issue date:
27 May 2009

Contact details:

Contact NICE about this project
Contact Address:

Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA

Links:

This page was last updated: 05 July 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright @ 2012 National Institute for Health and Clinical Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright @ 2012 National Institute for Health and Clinical Excellence. All rights reserved.